Unlike other slimming injections, the jab manufactured by US pharmaceutical giant Eli Lilly not only suppresses the appetite ...
A Sydney woman who went into premature menopause at just 32 is urging other women to get fertility tested before it’s too ...
Weight gain is common in women going through menopause. It can be caused by a variety of factors, including hormone ...
For women, there’s an added layer of complication: We are not the focus of the longevity lifehack movement, led by men like ...
Federal regulators say shortages of Ozempic and Wegovy have been resolved, as supplies of popular diabetes and obesity ...
The FDA has now resolved the shortages of Novo Nordisk and Eli Lilly’s blockbuster weight-loss drugs, which could spell the ...
A shortage of Danish drugmaker Novo Nordisk's popular weight-loss and diabetes drugs, Wegovy and Ozempic, has been resolved, ...
The FDA’s decision will threaten the ability of compounding pharmacies to make far cheaper, unbranded versions of the ...
2h
News Medical on MSNTargeting FGFR mutations offers new hope for bone repair in skeletal disordersGain-of-function mutations in fibroblast growth factor receptor (FGFR) genes are known to cause a range of skeletal disorders ...
The FDA announcement confirms that the U.S. supply of both prescription-only drugs now meets or exceeds the current and ...
The US Food and Drug Administration has approved a new drug application for a tablet version of Evrysdi (risdiplam) for people living with spinal muscular atrophy (SMA).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results